Review Article

Sphenoid Sinus Diseases: A Review of 1,442 Patients

Table 3

Sphenoid sinus lesion studies.

AuthorNumber of patientsMean age, yearsInfection/
inflammation
Miscellaneous

(1)Wyllie et al. 1973454877.8%17.8%4.4%
(2)Lawson and Reino 19971325160.6%31.8%7.6%
(3) Sethi 19992147.776.1%23.9%0.0%
(4)Cakmak et al. 200018256.661.5%34.6%3.9%
(5)Ruoppi et al. 20003946100.0%0%0%
(6)Hadar et al. 2002 (abstract)3891.0%9.0%0%
(7)Martin et al. 20022952.365.5%24.1%10.4%
(8)Wang et al. 200212244.780.3%13.1%6.6%
(9)Castelnuovo et al. 20054145.368.3%12.2%19.5%
(10)Friedman et al. 2005505172.0%20.0%8.0%
(11)Okuda et al. 2005
(abstract)
4491.0%9.0%0%
(12)Yu et al. 2006964388.6%10.4%1.0%
(13)Kim et al. 2008764575.0%25.0%
(14)Nour et al. 20084038.667.5%20.0%12.5%
(15)Socher et al. 200810968.8%15.6%15.6%
(16)Neyt and Jorissen 2009
(abstract)
4959.2%34.7%6.1%
(17)Fawaz et al. 2011
(abstract)
6659.0%36.5%4.5%
(18)Sieskiewicz et al. 20113244.368.8%18.7%12.5%
(19)Marcolini et al. 20154687.0%6.5%6.5%
(20)Celenk et al. 20152143.190.5%9.5%0%
(21)Beton et al. 20164240.761.9%23.8%14.3%
1,32046.574.8 %18.9%6.3%
95% confidence interval

This study12254.380.3%19.7%0%
Fooanant et al. 2017
Total1,44246.975.0%18.9%6.1%
95% confidence interval

Fibroosseous lesions were included in the tumor group.